Hepatic Effects of Estrogen on Plasma Distribution of Small Dense Low-Density Lipoprotein and Free Radical Production in Postmenopausal Women

Journal of Atherosclerosis and Thrombosis
Shota NiiAkihiko Wakatsuki

Abstract

Hepatic effects of estrogen therapy on low-density lipoprotein (LDL) subfraction or oxidative stress have not been previously evaluated. The purpose of the present study was to investigate whether the differential hepatic effects of estrogen affect plasma distribution of small dense LDL and free radical production in postmenopausal women. In all, 45 postmenopausal women were given 0.625 mg/day of oral conjugated equine estrogen (CEE) (n=15), 1.0 mg/day of oral 17β estradiol (E2) (n=15), or 50 μg/day of transdermal 17βE2 (n=15) for 3 months. Subjects received either estrogen alone or with dydrogesterone at 5 mg/day. Plasma concentrations of sex hormone-binding globulin (SHBG), lipids, metallic ions, and derivatives of reactive oxygen metabolites (d-ROMs) were measured. CEE, but not oral 17βE2, increased the plasma concentrations of triglyceride, copper (Cu), and d-ROMs and the ratio of small dense LDL/total LDL cholesterol, a marker for plasma distribution of small dense LDL. Transdermal 17βE2 decreased d-ROMs concentrations but did not significantly change other parameters. Plasma concentrations of SHBG increased in the 3 groups. Estrogen-induced changes in triglyceride correlated positively either with changes in SHBG (R=0.52,...Continue Reading

References

Nov 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J R McNamaraE J Schaefer
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
Sep 1, 1988·The Journal of Clinical Investigation·P H Iverius, J D Brunzell
Oct 1, 1985·Journal of Steroid Biochemistry·G L HammondP A Robinson
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U P SteinbrecherD Steinberg
Oct 1, 1994·Current Opinion in Lipidology·R M Krauss
Feb 20, 1998·Obstetrics and Gynecology·A WakatsukiY Sagara
Nov 7, 1998·European Journal of Clinical Nutrition·G BergH Brenner
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Sep 18, 2002·Journal of Lipid Research·Kaspar K Berneis, Ronald M Krauss
Aug 23, 2005·Climacteric : the Journal of the International Menopause Society·H Kuhl
Feb 10, 2006·Mymensingh Medical Journal : MMJ·S AkhterK Deb
Sep 19, 2006·Obstetrical & Gynecological Survey·Peter F Schnatz
Oct 2, 2008·European Heart Journal·Ellen LøkkegaardØjvind Lidegaard
Dec 17, 2009·Climacteric : the Journal of the International Menopause Society·C J Haines, E Farrell
Nov 6, 2010·Clinical Chemistry·Yasuki ItoTsutomu Hirano
Dec 24, 2010·Current Opinion in Nephrology and Hypertension·Xiao-Ping Yang, Jane F Reckelhoff
Apr 11, 2014·Journal of Atherosclerosis and Thrombosis·Ying Wang, Ira Tabas

❮ Previous
Next ❯

Citations

Oct 25, 2017·Climacteric : the Journal of the International Menopause Society·D PuJ Wu
Jul 15, 2021·Oxidative Medicine and Cellular Longevity·Du XiangYanfeng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.